유치의 활성치수치료에 적용한 국내 시판의 MTA 증례 보고
Korean Marketed MTA Applied to Vital Pulp Therapy in Primary Teeth: Case Reports
도래미, 심연수, 안소연, 김종빈,
소속 상세정보
도래미 ( Doh Re-Mee ) - 단국대학교 치과대학 통합치의학과
심연수 ( Shim Youn-Soo ) - 선문대학교 치위생학과
안소연 ( An So-Youn ) - 원광대학교 치과대학 소아치과학교실
김종빈 ( Kim Jong-Bin ) - 단국대학교 치과대학 소아치과학교실
KMID : 1146620180070010031
Abstract
Vital pulp therapies (VPT) include indirect pulp capping, direct pulp capping, partial (superficial) pulpotomy and complete (cervical) pulpotomy. They have gained prominence in recent years for several reasons. Mineral trioxide aggregate (MTA) was developed at Loma Linda University in the 1990s as a root-end filling material. It was subsequently approved by the US Federal Drug Administration, and became commercially available as ProRoot MTATM. On account of the favorable clinical properties of MTA, various MTA products have been developed in Korean market recently, which are commercially available, such as, Ortho MTATM, ENDOCEM MTATM, Retro MTATM, ENDOCEM ZrTM, BIODENTINETM and EZ-sealTM. The primary objective of pulp therapy is to restore the structure and function of teeth affected by caries or traumatic injury. The aim of this study was to examine the effects of MTA-induced biomineralization in primary teeth, using various MTA as the vital pulp treatment material.
키워드
Primary teeth; Mineral trioxide aggregate (MTA); Vital pulp therapy (VPT); Retro MTATM; ENDOCEM ZrTM; EZ-sealTM
원문 및 링크아웃 정보
등재저널 정보